Delivery Order SPE2DB22D3004-SPE2DB25FSD68
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $93,147.08 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on July 30, 2025. This firm fixed-price, non-set-aside contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The award represents a single delivery order execution under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a $23,545.12 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 28, 2025, and fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $16,979.99 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order represents a non-competitive award under the contractor's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,005.35 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 mg, a migraine treatment medication. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of NURTEC ODT 75 MG tablets (eight count) with a ceiling value of $10,819.64. This firm fixed price delivery order, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through competitive procurement with no set-aside designation. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $8,022.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, non-set-aside contract issued under a competitively awarded vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a $24,953.82 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) valued at $1,299.04 under a firm fixed-price contract type. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This contract utilizes no set-aside designation and reflects competitive procurement practices....
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSD68Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) valued at $5,818.86 under a firm fixed price contract type. This non-set-aside award was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The products will be delivered to Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant $999.9 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical running through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The current delivery order for NURTEC ODT—a migraine treatment medication—reflects the company's ongoing role as a critical vendor for federal medical procurement needs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 8/25/25 |